Infliximab in ankylosing spondylitis: The ASSERT (Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy) & IMPACT II (Infliximab Multinational Psoriatic Arthritis Controlled Trials)
The effect of infliximab on inflammation and bone formation biomarkers and associations with clinical response in ankylosing spondylitis and psoriatic arthritis